Company

Vividion Therapeutics

As of the edition of 20 October 2026, Vividion Therapeutics runs 4 drugs.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Active3
Stopped1
Total4

Where its trials are

  • Cancer: 4 trials led
  • Digestive system: 2 trials led
  • Inherited and neonatal: 1 trials led